Literature DB >> 23065570

Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase.

Lei Yan1, Keqiang Yan, Wang Kun, Lin Xu, Qian Ma, Yueqing Tang, Wei Jiao, Gangli Gu, Yidon Fan, Zhonghua Xu.   

Abstract

Berberine, a quaternary amine and isoquinoline alkaloid, has been proposed to have antimetastatic effects on many types of tumor cells; however, its exact inhibitory mechanisms with bladder cancer cells remain unclear. We used berberine and siRNA technology to interfere the expression of heparanase in bladder cancer T24 cells, detected the expression of heparanase mRNA and protein by reverse transcription PCR and Western blot respectively, and investigated their effects on the migration and invasion of T24 bladder cancer cells using transwell chamber. Our results showed that both mRNA and protein of heparanase were highly expressed in human bladder cancer T24 cells and markedly downregulated by both heparanase-specific siRNA (hpa-siRNA) and berberine. The tumor cell migration assay indicated that transfection of hpa-siRNA and treatment with berberine both attenuated the migration and invasion of T24 cells. Therefore, berberine inhibits the metastasis and invasion of bladder cancer cell, possibly via blocking the heparanase expression and thus may be used clinically to reduce the recurrence of bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065570     DOI: 10.1007/s13277-012-0531-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  25 in total

1.  Antisense-mediated suppression of Heparanase gene inhibits melanoma cell invasion.

Authors:  Madhuchhanda Roy; Jane Reiland; Brian P Murry; Vladimir Chouljenko; Konstantin G Kousoulas; Dario Marchetti
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

2.  Role of endothelial heparanase in delayed-type hypersensitivity.

Authors:  Evgeny Edovitsky; Immanuel Lerner; Eyal Zcharia; Tamar Peretz; Israel Vlodavsky; Michael Elkin
Journal:  Blood       Date:  2005-12-29       Impact factor: 22.113

3.  Heparanase expression correlates with malignant potential in human colon cancer.

Authors:  T Nobuhisa; Y Naomoto; T Ohkawa; M Takaoka; R Ono; T Murata; M Gunduz; Y Shirakawa; T Yamatsuji; M Haisa; J Matsuoka; H Tsujigiwa; H Nagatsuka; M Nakajima; N Tanaka
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-30       Impact factor: 4.553

4.  Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression.

Authors:  Victoria Cohen-Kaplan; Ilana Doweck; Inna Naroditsky; Israel Vlodavsky; Neta Ilan
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

5.  Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-alpha, iNOS, and IL-12 production in LPS-stimulated macrophages.

Authors:  Dong-Ung Lee; Young Jin Kang; Min Kyu Park; Young Soo Lee; Han Geuk Seo; Tae Sung Kim; Cheorl-Ho Kim; Ki Churl Chang
Journal:  Life Sci       Date:  2003-08-01       Impact factor: 5.037

6.  Anti-metastatic and anti-angiogenic activities of a new matrix metalloproteinase inhibitor, TN-6b.

Authors:  S J Lee; H Sakurai; K Oshima; S H Kim; I Saiki
Journal:  Eur J Cancer       Date:  2003-07       Impact factor: 9.162

7.  Function of heparanase in prostate tumorigenesis: potential for therapy.

Authors:  Immanuel Lerner; Leah Baraz; Eli Pikarsky; Amichay Meirovitz; Evgeny Edovitsky; Tamar Peretz; Israel Vlodavsky; Michael Elkin
Journal:  Clin Cancer Res       Date:  2008-01-22       Impact factor: 12.531

Review 8.  Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?

Authors:  F Fazioli; F Blasi
Journal:  Trends Pharmacol Sci       Date:  1994-01       Impact factor: 14.819

9.  Stable knockdown of heparanase expression in gastric cancer cells in vitro.

Authors:  Li-Duan Zheng; Guo-Song Jiang; Jia-Rui Pu; Hong Mei; Ji-Hua Dong; Xiao-Hua Hou; Qiang-Song Tong
Journal:  World J Gastroenterol       Date:  2009-11-21       Impact factor: 5.742

10.  Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma.

Authors:  S J Liu; Y M Sun; D F Tian; Y C He; L Zeng; Y He; C Q Ling; S H Sun
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

View more
  7 in total

1.  ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells.

Authors:  Lin Fu; Nan Liu; Yong Han; Chengyao Xie; Qingchang Li; Enhua Wang
Journal:  Tumour Biol       Date:  2014-06-18

2.  Validating antimetastatic effects of natural products in an engineered microfluidic platform mimicking tumor microenvironment.

Authors:  Yiming Niu; Jing Bai; Roger D Kamm; Yitao Wang; Chunming Wang
Journal:  Mol Pharm       Date:  2014-02-24       Impact factor: 4.939

3.  Berberine induces FasL-related apoptosis through p38 activation in KB human oral cancer cells.

Authors:  Jae-Sung Kim; Dahye Oh; Min-Ji Yim; Jin-Ju Park; Kyeong-Rok Kang; In-A Cho; Sung-Min Moon; Ji-Su Oh; Jae-Seek You; Chun Sung Kim; Do Kyung Kim; Sook-Young Lee; Gyeong-Je Lee; Hee-Jeong Im; Su-Gwan Kim
Journal:  Oncol Rep       Date:  2015-01-29       Impact factor: 3.906

4.  p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.

Authors:  Fang Zheng; Qin Tang; JingJing Wu; ShunYu Zhao; ZhanYang Liang; Liuning Li; WanYin Wu; Swei Hann
Journal:  J Exp Clin Cancer Res       Date:  2014-04-26

5.  Glucose-regulated protein 78 and heparanase expression in oral squamous cell carcinoma: correlations and prognostic significance.

Authors:  Fei Xia; Jin Cheng Xu; Pei Zhang; Yuan Yuan Zhang; Qian Wen Zhang; Zhen Hua Chao; Fang Wang
Journal:  World J Surg Oncol       Date:  2014-04-25       Impact factor: 2.754

6.  Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance.

Authors:  Chia-Hung Liu; Wan-Chun Tang; Peik Sia; Chi-Chen Huang; Pei-Ming Yang; Ming-Heng Wu; I-Lu Lai; Kuen-Haur Lee
Journal:  Int J Med Sci       Date:  2015-01-01       Impact factor: 3.738

7.  Global Trends in Research of Treatment on Bladder Cancer with Chinese Medicine Monomer from 2000 to 2021: A Bibliometric Analysis.

Authors:  Desheng Li; Minfang Zuo; Xinming Hu
Journal:  J Oncol       Date:  2022-09-19       Impact factor: 4.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.